Ochai S, Hassim A, Dekker E, Magome T, Lekota K, Makgabo S
PLoS Negl Trop Dis. 2024; 18(11):e0012122.
PMID: 39571005
PMC: 11620650.
DOI: 10.1371/journal.pntd.0012122.
Oh S, Chateau A, Tomatsidou A, Elli D, Gula H, Schneewind O
Res Microbiol. 2023; 174(6):104026.
PMID: 36646261
PMC: 10338639.
DOI: 10.1016/j.resmic.2023.104026.
Ochai S, Crafford J, Hassim A, Byaruhanga C, Huang Y, Hartmann A
Front Immunol. 2022; 13:814031.
PMID: 35237267
PMC: 8882864.
DOI: 10.3389/fimmu.2022.814031.
Bose S, Aggarwal S, Singh D, Acharya N
Microb Cell. 2020; 7(12):312-322.
PMID: 33335921
PMC: 7713254.
DOI: 10.15698/mic2020.12.737.
Morrow K, Frank D, Balczon R, Stevens T
Handb Exp Pharmacol. 2017; 238:67-85.
PMID: 28181005
PMC: 6103630.
DOI: 10.1007/164_2016_5003.
Progress toward the Development of a NEAT Protein Vaccine for Anthrax Disease.
Balderas M, Nguyen C, Terwilliger A, Keitel W, Iniguez A, Torres R
Infect Immun. 2016; 84(12):3408-3422.
PMID: 27647868
PMC: 5116719.
DOI: 10.1128/IAI.00755-16.
Tumor Targeting and Drug Delivery by Anthrax Toxin.
Bachran C, Leppla S
Toxins (Basel). 2016; 8(7).
PMID: 27376328
PMC: 4963830.
DOI: 10.3390/toxins8070197.
Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi.
Brown L, Wolf J, Prados-Rosales R, Casadevall A
Nat Rev Microbiol. 2015; 13(10):620-30.
PMID: 26324094
PMC: 4860279.
DOI: 10.1038/nrmicro3480.
Vaccine protection against Bacillus cereus-mediated respiratory anthrax-like disease in mice.
Oh S, Maier H, Schroeder J, Richter G, Elli D, Musser J
Infect Immun. 2013; 81(3):1008-17.
PMID: 23319564
PMC: 3584855.
DOI: 10.1128/IAI.01346-12.
Sortase-conjugation generates a capsule vaccine that protects guinea pigs against Bacillus anthracis.
Garufi G, Wang Y, Oh S, Maier H, Missiakas D, Schneewind O
Vaccine. 2012; 30(23):3435-44.
PMID: 22449424
PMC: 3538850.
DOI: 10.1016/j.vaccine.2012.03.023.
Anthrax edema toxin impairs clearance in mice.
Sastalla I, Tang S, Crown D, Liu S, Eckhaus M, Hewlett I
Infect Immun. 2011; 80(2):529-38.
PMID: 22104108
PMC: 3264307.
DOI: 10.1128/IAI.05947-11.
Antibody responses to a spore carbohydrate antigen as a marker of nonfatal inhalation anthrax in rhesus macaques.
Saile E, Boons G, Buskas T, Carlson R, Kannenberg E, Barr J
Clin Vaccine Immunol. 2011; 18(5):743-8.
PMID: 21389148
PMC: 3122534.
DOI: 10.1128/CVI.00475-10.
Cell cycle arrest induced by the bacterial adenylate cyclase toxins from Bacillus anthracis and Bordetella pertussis.
Gray M, Hewlett E
Cell Microbiol. 2010; 13(1):123-34.
PMID: 20946259
PMC: 4137770.
DOI: 10.1111/j.1462-5822.2010.01525.x.
A Bacillus anthracis S-layer homology protein that binds heme and mediates heme delivery to IsdC.
Tarlovsky Y, Fabian M, Solomaha E, Honsa E, Olson J, Maresso A
J Bacteriol. 2010; 192(13):3503-11.
PMID: 20435727
PMC: 2897652.
DOI: 10.1128/JB.00054-10.
BslA, the S-layer adhesin of B. anthracis, is a virulence factor for anthrax pathogenesis.
Kern J, Schneewind O
Mol Microbiol. 2009; 75(2):324-32.
PMID: 19906175
PMC: 2828814.
DOI: 10.1111/j.1365-2958.2009.06958.x.
Heme transfer to the bacterial cell envelope occurs via a secreted hemophore in the Gram-positive pathogen Bacillus anthracis.
Fabian M, Solomaha E, Olson J, Maresso A
J Biol Chem. 2009; 284(46):32138-46.
PMID: 19759022
PMC: 2797284.
DOI: 10.1074/jbc.M109.040915.
Anthrax vaccination strategies.
Cybulski Jr R, Sanz P, OBrien A
Mol Aspects Med. 2009; 30(6):490-502.
PMID: 19729034
PMC: 2783700.
DOI: 10.1016/j.mam.2009.08.006.
Cellular and systemic effects of anthrax lethal toxin and edema toxin.
Moayeri M, Leppla S
Mol Aspects Med. 2009; 30(6):439-55.
PMID: 19638283
PMC: 2784088.
DOI: 10.1016/j.mam.2009.07.003.
Lethal and edema toxins in the pathogenesis of Bacillus anthracis septic shock: implications for therapy.
Sherer K, Li Y, Cui X, Eichacker P
Am J Respir Crit Care Med. 2006; 175(3):211-21.
PMID: 17095744
PMC: 2176088.
DOI: 10.1164/rccm.200608-1239CP.
COMPARISON OF GRADED AND QUANTAL VIRULENCE TESTS FOR BACILLUS ANTHRACIS SPORES.
Fernelius A, Dearmon I, Klein F, LINCOLN R
J Bacteriol. 1960; 79(4):594-600.
PMID: 16561854
PMC: 278737.
DOI: 10.1128/jb.79.4.594-600.1960.
